Broad Institute of MIT and Harvard to receive European patent for CRISPR-Cpf1 – pharmabiz.com
|
Broad Institute of MIT and Harvard to receive European patent for CRISPR–Cpf1
pharmabiz.com CRISPR–Cpf1 holds the potential for simpler and more precise genome engineering than has been available with CRISPR-Cas9. Feng Zhang and collaborators elucidated the mechanism and harnessed the Cpf1 system for gene editing in human cells in a … |
